Dimensional Fund Advisors
ANIK icon

Dimensional Fund Advisors’s Anika Therapeutics ANIK Stock Holding History

Dimensional Fund Advisors’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.65M Sell
458,847
-35,472
-7% -$412K ﹤0.01% 2405
2025
Q4 		$4.75M Sell
494,319
-106,844
-18% -$1.02M ﹤0.01% 2543
2025
Q3 		$5.65M Sell
601,163
-21,921
-4% -$209K ﹤0.01% 2511
2025
Q2 		$6.59M Buy
623,084
+9,112
+1% +$115K ﹤0.01% 2437
2025
Q1 		$9.23M Sell
613,972
-43,383
-7% -$722K ﹤0.01% 2283
2024
Q4 		$10.8M Sell
657,355
-50,011
-7% -$986K ﹤0.01% 2276
2024
Q3 		$17.5M Sell
707,366
-41,918
-6% -$1.09M ﹤0.01% 2066
2024
Q2 		$19M Sell
749,284
-60,471
-7% -$1.57M 0.01% 1979
2024
Q1 		$20.6M Sell
809,755
-11,697
-1% -$283K 0.01% 1970
2023
Q4 		$18.6M Sell
821,452
-38,683
-4% -$800K 0.01% 2023
2023
Q3 		$16M Sell
860,135
-117,727
-12% -$2.44M 0.01% 2039
2023
Q2 		$25.4M Sell
977,862
-438
-0% -$11.7K 0.01% 1805
2023
Q1 		$28.1M Buy
978,300
+18,554
+2% +$552K 0.01% 1729
2022
Q4 		$28.4K Buy
959,746
+19,944
+2% +$567K 0.01% 1679
2022
Q3 		$22.4M Buy
939,802
+38,915
+4% +$896K 0.01% 1758
2022
Q2 		$20.1M Buy
900,887
+30,588
+4% +$682K 0.01% 1863
2022
Q1 		$21.9M Buy
870,299
+14,175
+2% +$432K 0.01% 1922
2021
Q4 		$30.7M Sell
856,124
-5,809
-0.7% -$233K 0.01% 1744
2021
Q3 		$36.7M Buy
861,933
+8,213
+1% +$338K 0.01% 1642
2021
Q2 		$37M Sell
853,720
-6,834
-0.8% -$291K 0.01% 1680
2021
Q1 		$35.2M Sell
860,554
-23,562
-3% -$894K 0.01% 1705
2020
Q4 		$40M Sell
884,116
-37,464
-4% -$1.42M 0.01% 1551
2020
Q3 		$32.6M Sell
921,580
-9,752
-1% -$352K 0.01% 1537
2020
Q2 		$35.1M Sell
931,332
-10,901
-1% -$359K 0.02% 1495
2020
Q1 		$27.2M Sell
942,233
-59,061
-6% -$2.39M 0.01% 1542
2019
Q4 		$51.9M Sell
1,001,294
-43,697
-4% -$2.54M 0.02% 1388
2019
Q3 		$57.4M Sell
1,044,991
-4,314
-0.4% -$221K 0.02% 1266
2019
Q2 		$42.6M Buy
1,049,305
+25,126
+2% +$916K 0.02% 1571
2019
Q1 		$31M Buy
1,024,179
+26,738
+3% +$916K 0.01% 1802
2018
Q4 		$33.5M Sell
997,441
-44
-0% -$1.59K 0.02% 1640
2018
Q3 		$42.1M Buy
997,485
+19,916
+2% +$787K 0.02% 1634
2018
Q2 		$31.3M Buy
977,569
+46,798
+5% +$1.93M 0.01% 1846
2018
Q1 		$46.3M Buy
930,771
+29,467
+3% +$1.66M 0.02% 1431
2017
Q4 		$48.6M Buy
901,304
+5,704
+0.6% +$316K 0.02% 1379
2017
Q3 		$51.9M Buy
895,600
+17,594
+2% +$920K 0.02% 1264
2017
Q2 		$43.3M Buy
878,006
+106,307
+14% +$4.9M 0.02% 1400
2017
Q1 		$33.5M Buy
771,699
+40,020
+5% +$1.91M 0.02% 1595
2016
Q4 		$35.8M Buy
731,679
+1,755
+0.2% +$81.1K 0.02% 1489
2016
Q3 		$34.9M Sell
729,924
-18,159
-2% -$897K 0.02% 1435
2016
Q2 		$40.1M Sell
748,083
-33,113
-4% -$1.56M 0.02% 1204
2016
Q1 		$34.9M Buy
781,196
+6,171
+0.8% +$250K 0.02% 1316
2015
Q4 		$29.6M Buy
775,025
+41,155
+6% +$1.57M 0.02% 1414
2015
Q3 		$23.4M Buy
733,870
+14,809
+2% +$516K 0.02% 1581
2015
Q2 		$23.8M Buy
719,061
+7,836
+1% +$279K 0.01% 1667
2015
Q1 		$29.3M Sell
711,225
-91,843
-11% -$3.71M 0.02% 1406
2014
Q4 		$32.7M Sell
803,068
-145,864
-15% -$5.7M 0.02% 1207
2014
Q3 		$34.8M Sell
948,932
-2,198
-0.2% -$95K 0.02% 1009
2014
Q2 		$44.1M Buy
951,130
+20,644
+2% +$918K 0.03% 823
2014
Q1 		$38.2M Buy
930,486
+13,808
+2% +$513K 0.03% 873
2013
Q4 		$35M Buy
916,678
+37,864
+4% +$1.17M 0.03% 917
2013
Q3 		$21.1M Buy
878,814
+40,102
+5% +$900K 0.02% 1362
2013
Q2 		$14.3M Buy
+838,712
New +$12.1M 0.01% 1661

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors's ANIK Position: Q1 2026 in Review

Dimensional Fund Advisors reduced its Anika Therapeutics (ANIK) stake by 7.2% in Q1 2026, selling an estimated $412K and leaving 458,847 shares worth $6.65M. The position accounts for ﹤0.01% of the portfolio, ranked #2405.

Dimensional Fund Advisors first reported a position in ANIK in Q2 2013 and has held it in 52 quarters since. The position peaked at $57.4M in Q3 2019. 130 funds tracked by Wall St. Rank hold ANIK as of Q1 2026.

  • Dimensional Fund Advisors held 458,847 shares of Anika Therapeutics worth $6.65M as of Q1 2026.
  • Dimensional Fund Advisors sold 35,472 Anika Therapeutics shares in Q1 2026, an estimated $412K.
  • Anika Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2405 holding.
  • Dimensional Fund Advisors first reported a position in Anika Therapeutics in Q2 2013 and has held it in 52 quarters since.
  • Dimensional Fund Advisors's Anika Therapeutics position peaked at $57.4M in Q3 2019.
  • 130 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.